Abstract
By May 29, 2020, all 50 states in the United States had reopened their economies to some extent after the coronavirus lockdown. Although there are many debates about whether states reopened their economies too early, no study has examined this effect quantitatively. This paper takes advantage of the daily cases, deaths, and test data at the state level, and uses the synthetic control method to address this question. I find that reopening the economy caused an additional 2000 deaths in the 6 states (Alabama, Colorado, Georgia, Mississippi, Tennessee, and Texas) that reopened before May 1st by three weeks after reopening. It also increased daily confirmed cases by 40%, 52%, and 53% after the first, second, and third week of reopening, respectively. Moreover, contrary to scientists’ prescription that expanding tests is a necessary condition for reopening, these states witnessed a decline in daily tests by 17%, 47%, and 31% after the first, second, and third week of reopening, respectively.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This study doesn't involve any clinical trial. I use the publicly available data to assess the social and economic impact of reopening the economy in the US during COVID-19 pandemic.
Funding Statement
No external funding was received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data and STATA do files are available on request.
